NCT05435976

Brief Summary

The general objective of the study is to confirm the medium/long-term safety and clinical performance of the CELLIS Dental membrane used in dental surgery and to identify emerging risks in comparison to clinical data related to other treatment modalities. The present study will be a prospective multicentric non-randomized and noncontrolled trial involving 50 patients followed for 24 months. The study will be conducted in France in 4 investigational centres.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for all trials

Timeline
8mo left

Started Sep 2022

Longer than P75 for all trials

Geographic Reach
1 country

5 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Sep 2022Dec 2026

First Submitted

Initial submission to the registry

June 22, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 28, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

September 12, 2022

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

September 29, 2025

Status Verified

September 1, 2025

Enrollment Period

4.3 years

First QC Date

June 22, 2022

Last Update Submit

September 24, 2025

Conditions

Keywords

dental regeneration of soft tissuebiological mesh

Outcome Measures

Primary Outcomes (1)

  • Rate of adverse events including reoperation following a complication and matrix removal

    Percentage

    From the surgical procedure throughout the entire 24-month follow-up period

Secondary Outcomes (7)

  • Evaluation of periodontium thickness

    Before surgery and at the 15-day and 3-month follow-up visits

  • Evaluation of keratinized tissue width

    Before surgery and at the 15-day and 3-month follow-up visits

  • Evaluation of the periodontal biotype

    Before surgery and at the 15-day, 3-month, 12-months and 24-months follow-up visits

  • Surgeon aesthetic evaluation using a visual analogue scale (VAS) scored from 1 to 10 (1=unsatisfactory; 10=very satisfactory).

    At the 15-day, 3-month, 12-months and 24-months follow-up visits

  • Patient-reported pain using a visual analogue scale (VAS) scored from 0 to 10 (0=no pain; 10=worse pain).

    At the 15-day, 3-month, 12-months and 24-months follow-up visits

  • +2 more secondary outcomes

Interventions

Biological membranes used in dental surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult with an indication of keratinized soft tissue regeneration in the buccal cavity and/or keratinized soft tissue development around teeth or implants

You may qualify if:

  • Patient aged ≥18 years,
  • Patient with an indication of keratinized soft tissue regeneration in the buccal cavity and/or keratinized soft tissue development around teeth or implants,
  • Patient being informed of his participation to the study and of the follow-up visits, and having given his written informed consent,
  • Patient being informed of the porcine origin of the device in advance of the procedure.

You may not qualify if:

  • Patient with known hypersensitivity to porcine materials,
  • Patient with acute or chronic infection or inflammation of the buccal cavity,
  • Patient with a general illness contra-indicated for implantology, periodontology, stomatology, cranio-maxillo-facial surgery,
  • Patient who is pregnant,
  • Patient who is incapacitated including protected and deprived of liberty person,
  • Patient having refused to participate in the study,
  • Patient refusing to return for the follow-up visits.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Cabinet dentaire Grange Blanche

Lyon, France

Location

Cabinet PISB

Saint-Brieuc, France

Location

CMCT (Centre Médico-Chirurgical de Touraine)

Saint-Cyr-sur-Loire, 37540, France

Location

Cabinet dentaire des chênes

Saint-Pierre-du-Mont, France

Location

Cabinet dentaire Saint Priest en Jarez

Saint-Priest-en-Jarez, France

Location

Study Officials

  • Rémy CAHUZAC

    Cabinet dentaire des chênes, Saint Pierre du Mont, France

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2022

First Posted

June 28, 2022

Study Start

September 12, 2022

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

September 29, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations